CVS Health Co. (NYSE:CVS) Shares Bought by Weatherly Asset Management L. P.

Weatherly Asset Management L. P. lifted its stake in shares of CVS Health Co. (NYSE:CVS) by 12.4% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 15,426 shares of the pharmacy operator’s stock after acquiring an additional 1,699 shares during the period. Weatherly Asset Management L. P.’s holdings in CVS Health were worth $970,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of CVS. Capital Advisors Inc. OK grew its stake in shares of CVS Health by 1.7% in the 3rd quarter. Capital Advisors Inc. OK now owns 15,711 shares of the pharmacy operator’s stock valued at $988,000 after buying an additional 261 shares during the period. Gladstone Institutional Advisory LLC lifted its holdings in CVS Health by 24.2% in the third quarter. Gladstone Institutional Advisory LLC now owns 14,556 shares of the pharmacy operator’s stock valued at $915,000 after acquiring an additional 2,832 shares during the last quarter. Silver Coast Investments LLC grew its position in CVS Health by 16.0% in the third quarter. Silver Coast Investments LLC now owns 8,950 shares of the pharmacy operator’s stock worth $563,000 after acquiring an additional 1,236 shares during the period. Focus Financial Network Inc. increased its stake in CVS Health by 2.9% during the third quarter. Focus Financial Network Inc. now owns 18,061 shares of the pharmacy operator’s stock worth $1,136,000 after acquiring an additional 512 shares during the last quarter. Finally, Reston Wealth Management LLC purchased a new stake in CVS Health in the third quarter valued at $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Down 1.2 %

Shares of NYSE CVS opened at $55.81 on Friday. The business has a 50-day moving average of $59.66 and a two-hundred day moving average of $59.62. The company has a market capitalization of $70.21 billion, a price-to-earnings ratio of 9.93, a price-to-earnings-growth ratio of 0.83 and a beta of 0.54. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. During the same period in the prior year, the company posted $2.21 earnings per share. The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. On average, analysts forecast that CVS Health Co. will post 6.41 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.77%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s payout ratio is 47.33%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on CVS shares. Truist Financial raised their price objective on CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a research report on Friday, October 11th. TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $59.00 to $85.00 in a research report on Friday, October 4th. Royal Bank of Canada restated an “outperform” rating and issued a $68.00 price objective on shares of CVS Health in a report on Wednesday, September 4th. Mizuho cut their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Nine analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $74.58.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.